Debt-to-equity of Harmony Biosciences Holdings, Inc. from 30 Jun 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Harmony Biosciences Holdings, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 31 Dec 2025.
  • Harmony Biosciences Holdings, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 45%, a 21% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Harmony Biosciences Holdings, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 45% -12% -21% 31 Dec 2025
Q3 2025 46% -16% -26% 30 Sep 2025
Q2 2025 49% -16% -24% 30 Jun 2025
Q1 2025 53% -11% -18% 31 Mar 2025
Q4 2024 57% -6% -9.5% 31 Dec 2024
Q3 2024 63% +1.2% +1.9% 30 Sep 2024
Q2 2024 65% -2.2% -3.3% 30 Jun 2024
Q1 2024 64% -13% -17% 31 Mar 2024
Q4 2023 63% -26% -29% 31 Dec 2023
Q3 2023 62% -45% -42% 30 Sep 2023
Q2 2023 67% -58% -46% 30 Jun 2023
Q1 2023 77% -66% -46% 31 Mar 2023
Q4 2022 89% -76% -46% 31 Dec 2022
Q3 2022 106% -107% -50% 30 Sep 2022
Q2 2022 124% -115% -48% 30 Jun 2022
Q1 2022 143% 31 Mar 2022
Q4 2021 166% 31 Dec 2021
Q3 2021 213% 30 Sep 2021
Q2 2021 239% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.